SCHEMBL7149882

SCHEMBL7149882

CN1CCSC1Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CCR3 P51677 2/20 0.40
CARM1 Q86X55 2/20 0.40
PRMT6 Q96LA8 2/20 0.40
PRMT3 O60678 1/20 0.39
PRMT1 Q99873 1/20 0.39
PRMT8 Q9NR22 1/20 0.39
KCNH2 Q12809 1/20 0.39
CYP3A4 P08684 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MC4R P32245 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19468240 0.72 MGLL (0.40) CCR3
SCHEMBL1831035 0.71 CCR3 (0.46) CCR3CARM1PRMT6PRMT3PRMT1
SCHEMBL15586710 0.70
SCHEMBL155410 0.69 RIPK1 (0.54)
SCHEMBL903058 0.69 ABCB1 (0.47)
SCHEMBL11572447 0.69 ABCB1 (0.47)
SCHEMBL327856 0.68 CCR3 (0.66) CCR3CARM1PRMT6PRMT3PRMT1
SCHEMBL3436965 0.67 PRMT6 (0.62) CCR3CARM1PRMT6PRMT3PRMT1
SCHEMBL16707757 0.67 MC4R (0.49) CCR3MC4R
SCHEMBL9025379 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6524571-B1 Insertion of a methioninase gene into tumor cells, optionally in combination with administration of methioninase, methionine deprivation or administration of a chemotherapeutic agent, retrovirus or adenovirus ANTICANCER, INC. 2003-02-25 US disclosed
EP-1133567-A1 METHIONINASE GENE THERAPY FOR TUMOR TREATMENT ANTICANCER, INC. (US) 2001-09-19 EP disclosed
WO-2000029589-A9 METHIONINASE GENE THERAPY FOR TUMOR TREATMENT ANTICANCER INC (US) 2001-04-19 WO disclosed
WO-2000029589-A1 METHIONINASE GENE THERAPY FOR TUMOR TREATMENT ANTICANCER, INC. (US) 2000-05-25 WO disclosed